Robert Lorne Hopfner, Director of Evommune EVMN, has filed 8 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $17.4K. The latest trade was on 25/12/19.

RH

RH

Robert Lorne Hopfner

Director

Company

Evommune EVMN

First filing

23/03/30

Trades

30 trades

Buys / sales

8 / 0

12-month net buying

$17.4K

Last trade

25/12/19

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
EvommuneEVMN	Open-market buy	25/12/19	25/12/22	1,000 sh	$17.35	$17,350	+33.0%
IP Inozyme Pharma	Open-market buy	23/08/01	23/08/03	833,333 sh2 trades	$4.80avg.	$3,999,998.4	+112.9%
IP Inozyme Pharma	Open-market buy	23/05/11–23/05/12	23/05/15	447,932 sh2 trades	$6.36avg.	$2,849,997.9	+13.9%
IP Inozyme Pharma	Open-market buy	23/03/29	23/03/30	344,592 sh	$4.54	$1,564,447.68	+12.0%
IP Inozyme Pharma	Open-market buy	23/03/27–23/03/28	23/03/29	207,840 sh2 trades	$4.05avg.	$841,120.36	+7.8%